Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.



Revenue & Earnings

Revenue (FY) $23,362.00
EBIT (Mil) (FY) $9,721.00
EBIT (Mil) (MRQ) $2,453.00
EBIT (Mil) (TTM) $9,179.00
EBITDA (Mil) (FY) $11,927.00
EBITDA (Mil) (MRQ) $3,354.00
EBITDA (Mil) (TTM) $12,609.00
Net Income Excluding Extraordinary Items (Mil) (FY) $7,842.00
Net Income Including Extraordinary Items (Mil) (FY) $7,842.00
Diluted EPS Excluding Extraordinary Items (FY) $12.88
Diluted EPS Including Extraordinary Items (FY) $12.88


Yield (%) 2.82
Dividend Record Date 11/16/20
Dividend Rate 6.40%


Price to Revenue (TTM) $5.29
Price to Revenue (MRQ) $5.13
Price to Revenue (FY) $5.65
Price To Cash Flow (TTM) $12.25
Price to Cash Flow (MRQ) $11.27
Price to Cash Flow (FY) $13.15
Price to Book (MRQ) $12.08
Price to Book (FY) $13.87
Total Debt to Equity (MRQ) (%) 312.87%
Total Debt to Equity (FY) (%) 309.14%
Current Ratio (MRQ) $2.28
Current Ratio (FY) $1.44


5-Year Annual Dividend Growth Rate (%) 18.91%
5-Year Annual Revenue Growth Rate (%) 3.09%

FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.

Copyright Refinitiv